Interest of Animal-assisted Therapy With Dogs in the Treatment of Depression

NCT ID: NCT06449690

Last Updated: 2024-06-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

58 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-01

Study Completion Date

2026-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a randomized controlled trial (comparing "occupational activities" versus "dog-assisted therapy" arms) investigating the effectiveness of animal-assisted therapy with dogs in small groups of participants with depression. Patients in the "dog-assisted therapy" arm will participate in two group sessions (groups of 3 to 7 participants) of canine-assisted therapy, supervised by a healthcare professional certified in animal-assisted therapy alongside a psychiatric caregiver, for 30 minutes each week over 6 weeks. Patients in the "occupational activities" arm will participate in two group sessions (groups of 3 to 7 participants) of occupational activities, supervised by a healthcare professional experienced in group occupational activities alongside a psychiatric caregiver, for 30 minutes each week over 6 weeks.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dog-assisted therapy

Patients in the "dog-assisted therapy" arm will participate in two group sessions (groups of 3 to 7 participants) of canine-assisted therapy, supervised by a healthcare professional certified in animal-assisted therapy alongside a psychiatric caregiver, for 30 minutes each week over 6 weeks.

Group Type EXPERIMENTAL

Dog-assisted therapy

Intervention Type PROCEDURE

Dog-assisted therapy consists of the search for positive interactions resulting from the intentional human-animal relationship in the educational, therapeutic or social fields, practices as they are conducted in educational and medico-social institutions for example.

Occupational activities

Patients in the "occupational activities" arm will participate in two group sessions (groups of 3 to 7 participants) of occupational activities, supervised by a healthcare professional experienced in group occupational activities alongside a psychiatric caregiver, for 30 minutes each week over 6 weeks.

Group Type ACTIVE_COMPARATOR

Occupational activities

Intervention Type PROCEDURE

Occupational activities consist of origami, relaxation, sports or board games sessions.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dog-assisted therapy

Dog-assisted therapy consists of the search for positive interactions resulting from the intentional human-animal relationship in the educational, therapeutic or social fields, practices as they are conducted in educational and medico-social institutions for example.

Intervention Type PROCEDURE

Occupational activities

Occupational activities consist of origami, relaxation, sports or board games sessions.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient aged 18 to 65
* Patient affiliated with a social security scheme
* Patient hospitalized under voluntary psychiatric care
* Diagnosis of depression according to DSM-5-TR criteria
* QIDS-C16 score ≥11 at screening
* QIDS-SR16 score ≥11 at screening and inclusion

Exclusion Criteria

* Severe comorbid psychiatric disorder
* Imminent risk of suicidal behavior
* Unstable comorbid somatic condition
* Vulnerable patients (under guardianship, curatorship, or judicial protection)
* Known fear of dogs
* Known allergy to dog fur
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondation Bon Sauveur De La Manche

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jérémy MADIGAND, MD

Role: PRINCIPAL_INVESTIGATOR

Fondation Bon Sauveur De La Manche

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ludovic PRIME, MSc

Role: CONTACT

+33 2 33 77 77 77

References

Explore related publications, articles, or registry entries linked to this study.

Bousman CA, Arandjelovic K, Mancuso SG, Eyre HA, Dunlop BW. Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials. Pharmacogenomics. 2019 Jan;20(1):37-47. doi: 10.2217/pgs-2018-0142. Epub 2018 Dec 6.

Reference Type BACKGROUND
PMID: 30520364 (View on PubMed)

Lundqvist M, Carlsson P, Sjodahl R, Theodorsson E, Levin LA. Patient benefit of dog-assisted interventions in health care: a systematic review. BMC Complement Altern Med. 2017 Jul 10;17(1):358. doi: 10.1186/s12906-017-1844-7.

Reference Type BACKGROUND
PMID: 28693538 (View on PubMed)

Richerson JT, Wagner TH. Service Dogs for Veterans With PTSD. Psychiatr Serv. 2023 Jun 1;74(6):668-669. doi: 10.1176/appi.ps.20230164. No abstract available.

Reference Type BACKGROUND
PMID: 37259586 (View on PubMed)

Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, Niederehe G, Thase ME, Lavori PW, Lebowitz BD, McGrath PJ, Rosenbaum JF, Sackeim HA, Kupfer DJ, Luther J, Fava M. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006 Nov;163(11):1905-17. doi: 10.1176/ajp.2006.163.11.1905.

Reference Type BACKGROUND
PMID: 17074942 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

N° ID-RCB : 2024-A00645-42

Identifier Type: OTHER

Identifier Source: secondary_id

FBSM-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Imagery Rescripting in Depression
NCT03299127 COMPLETED NA
bWell-D Pilot Randomized Controlled Trial
NCT06546917 NOT_YET_RECRUITING NA
Meditation for Depression
NCT01671436 COMPLETED NA